A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Non-Squamous Non-Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Dingzhi Huang, MD) · zlyyfnkdoc@163.com · 18622221232
  • Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Yun Fan, M.D.) · fanyun@zjcc.org.cn · 13858182310
Study leads
  • Dingzhi Huang, M.D.

    Principal Investigator

    Tianjin Medical University Cancer Institute and Hospital

  • Yun Fan, M.D.

    Principal Investigator

    Zhejiang Cancer Hospital